keyword
https://read.qxmd.com/read/38543152/niosomal-bupropion-exploring-therapeutic-frontiers-through-behavioral-profiling
#1
JOURNAL ARTICLE
Karthick Harini, Suliman Yousef Alomar, Mohammed Vajagathali, Salim Manoharadas, Anbazhagan Thirumalai, Koyeli Girigoswami, Agnishwar Girigoswami
Bupropion (Bup) belongs to the norepinephrine-dopamine reuptake inhibitor (NDRI) class and it is the only FDA-approved drug of its class for the treatment of major depressive disorder (MDD), sold under the name of Wellbutrin. Although bupropion is effective in suppressing the symptoms, its regular use and overdose might lead to seizures and liver failure. Thus, we aimed to nanoformulate bupropion onto a niosomal vesicle to improve its efficacy and achieve the same therapeutic effect at lower scheduled doses...
March 12, 2024: Pharmaceuticals
https://read.qxmd.com/read/38467432/-pharmacogenetic-influence-on-stereoselective-steady-state-disposition-of-bupropion
#2
JOURNAL ARTICLE
Evan D Kharasch, Eric J Lenze
Bupropion is used for treating depression, obesity, seasonal affective disorder, and for smoking cessation. Bupropion is commonly-prescribed, but has complex pharmacokinetics and interindividual variability in metabolism and bioactivation may influence therapeutic response, tolerability and safety. Bupropion is extensively and stereoselectively metabolized, the metabolites are pharmacologically active, and allelic variation in CYP2B6 affects clinical hydroxylation of single-dose bupropion. Genetic effects on stereoselective disposition of steady-state bupropion are not known...
March 11, 2024: Drug Metabolism and Disposition: the Biological Fate of Chemicals
https://read.qxmd.com/read/38133585/drugs-for-depressionr
#3
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 11, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/37909713/patient-interest-in-acupuncture-for-smoking-cessation-a-survey
#4
JOURNAL ARTICLE
Kelsey M Sicker, Michelle Secic, Anna Graham, Stephen E Auciello
BACKGROUND/OBJECTIVE: Tobacco use remains the leading cause of preventable death in the United States. The most widely available treatment options to assist patients in smoking cessation are limited by side effects and moderate efficacy at best. Acupuncture may be an effective option for smoking cessation. The goal of this study was to establish the need for and interest in acupuncture therapy to potentially assist with smoking cessation from a patient perspective. METHODS: We conducted a cross-sectional survey study among patients aged 18 years or older whose medical record reported current tobacco use with English as their preferred language...
November 1, 2023: Acupuncture in Medicine: Journal of the British Medical Acupuncture Society
https://read.qxmd.com/read/37885535/transcranial-magnetic-stimulation-in-bipolar-ii-disorder-treatment-a-case-report
#5
Nga N Tran, Sydney Hutto, Landon R Thompson, Aaron Hawkins
The objective of this case report is to describe and document the use of transcranial magnetic stimulation (TMS) to aid in the treatment of bipolar II disorder. A 35-year-old male with a past medical history of attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), severe depression, and bipolar II disorder was presented to an outpatient psychiatric clinic 1.5 years after his initial TMS treatment for TMS maintenance therapy. He reported feeling depressed, brain fogginess, loss of concentration, fatigue, and constant changes in moods...
September 2023: Curēus
https://read.qxmd.com/read/37807161/a-46-mild-neurocognitive-disorder-due-to-multiple-etiologies-case-study
#6
JOURNAL ARTICLE
Katelyn Felegy, Julie Keaveney
OBJECTIVE: Frank, a 68-year-old male, is seeking a neuropsychological evaluation based on a referral from the concussion legacy foundation. He wants to know if he has impairment and if so, what the cause is. He has been told by previous providers that he has Lewy Body Dementia, Alzheimer's Disease, or CTE. METHOD: Frank has had over 20 concussions from football, car accidents, and assaults. For approximately a year, Frank has noticed short-term memory loss, word-finding problems, difficulty concentrating, and forgetting things...
October 8, 2023: Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists
https://read.qxmd.com/read/36542346/dextromethorphan-bupropion-auvelity-for-depression
#7
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 26, 2022: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36297308/determination-of-bupropion-and-its-impurities-via-a-chaotropic-chromatography-method-following-analytical-quality-by-design-principles-for-method-development
#8
JOURNAL ARTICLE
Kostas Gkountanas, Anđelija Malenović, Yannis Dotsikas
A novel chaotropic chromatography method for the quantitative determination of bupropion and its impurities, following analytical quality-by-design (AQbD) principles, is presented. The analytical target profile (ATP) was defined on the basis of the efficient separation and reliable determination of bupropion and its five impurities in tablets. Preliminary experiments revealed the need for the addition of a gradient elution part. A screening fractional factorial experimental design was employed to select the critical method parameters (CMPs) and a Box-Behnken design (BBD) was utilized to investigate their influence on predefined critical method attributes (CMAs)...
September 28, 2022: Pharmaceuticals
https://read.qxmd.com/read/34745784/erythrodermic-psoriasis-exacerbated-by-bupropion
#9
Michael G Foss, Timothy Nyckowski, William Steffes
Erythroderma is a rare, potentially life-threatening presentation of psoriasis that can be triggered by medication reactions. Bupropion is indicated for major depressive disorder (Wellbutrin®, GlaxoSmithKline, Research Triangle Park, NC), smoking cessation (Zyban®, GlaxoSmithKline, Research Triangle Park, NC), and weight loss (when in formulation with naltrexone ER; Contrave®, Orixegen Therapeutics, La Jolla, CA). Bupropion can exacerbate psoriasis, however, this is an under-recognized side effect of the medication, particularly in the United States...
October 2021: Curēus
https://read.qxmd.com/read/32835701/formulation-characterization-and-comparative-pharmacokinetic-study-of-bupropion-floating-raft-system-as-a-promising-approach-for-treating-depression
#10
JOURNAL ARTICLE
Mahmoud H Teaima, Magdi M Abdel Hamid, Nabil A Shoman, Bhaskara R Jasti, Mohamed A El-Nabarawi, Mohamed Yasser
The aim of this study was to formulate, evaluate, and compare satiety-enhancing floating raft system (FRS) of bupropion as gastroretentive drug delivery systems (GRDDS) using in-situ gelling pectin and alginate. Bupropion was considered as a good candidate for such systems due to high water solubility that requires frequent dosing. Pectin and alginate could prolong satiety sensation augmenting weight loss of bupropion. A 24 full factorial design was tailored to inspect the effect of the response variables (gel-forming polymer type, calcium carbonate percentage, glyceride lipid type and percentage)...
November 2020: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/32764875/promising-swellable-floating-bupropion-tablets-formulation-in-vitro-in-vivo-evaluation-and-comparative-pharmacokinetic-study-in-human-volunteers
#11
COMPARATIVE STUDY
Mahmoud Teaima, Magdi M Abdel Hamid, Nabil A Shoman, Bhaskara R Jasti, Mohamed A El-Nabarawi
PURPOSE: Bupropion is an antidepressant drug that facilitates weight loss. It is a highly water-soluble drug that needs multiple dosing, so it is considered a potential candidate for oral controlled-release dosage form. The aim of this research was to formulate and evaluate satiety-inducing swellable floating bupropion tablets by direct compression targeting depression associated with eating disorders. Various combinations of natural and semi-synthetic hydrogels were selected to achieve maximum swelling and remaining buoyant in the stomach...
2020: Drug Design, Development and Therapy
https://read.qxmd.com/read/32331059/174-catatonia-complicated-by-encephalopathy-diagnostic-and-treatment-challenges
#12
JOURNAL ARTICLE
Sree Latha Krishna Jadapalle
The term Catatonia was coined by Kraepelin in 1893 and was categorized as a subtype of dementia praecox. Bleuler in 1906 redefined it as catatonic Schizophrenia. Over the period of time by accumulating evidence of various case reports and studies its apparent that catatonia is not only seen in Schizophrenia, Affective disorders but is also seen secondary to various medical problems. There is very limited literature describing catatonia in the presence of neurological problems like Encephalopathy. The pathophysiology of Catatonia remains unclear...
April 2020: CNS Spectrums
https://read.qxmd.com/read/30406443/neuropharmacology-of-synthetic-cathinones
#13
JOURNAL ARTICLE
Michael H Baumann, Hailey M Walters, Marco Niello, Harald H Sitte
Synthetic cathinones are derivatives of the naturally occurring compound cathinone, the main psychoactive ingredient in the khat plant Catha edulis. Cathinone is the β-keto analog of amphetamine, and all synthetic cathinones display a β-keto moiety in their structure. Several synthetic cathinones are widely prescribed medications (e.g., bupropion, Wellbutrin® ), while others are problematic drugs of abuse (e.g., 4-methylmethcathinone, mephedrone). Similar to amphetamines, synthetic cathinones are psychomotor stimulants that exert their effects by impairing the normal function of plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and 5-HT (SERT)...
November 8, 2018: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/28631318/bupropion-overdose-resulted-in-a-pharmacobezoar-in-a-fatal-bupropion-wellbutrin-%C3%A2-sustained-release-overdose-postmortem-distribution-of-bupropion-and-its-major-metabolites
#14
Gregory Schmit, Evy De Boosere, Jessica Vanhaebost, Arnaud Capron
Bupropion (BUP) overdose commonly causes generalized seizures and central nervous system depression. The case of a 28-year-old woman who died from a massive lethal overdose with sustained-release bupropion (Wellbutrin® 300 mg) is herein presented. The autopsy revealed the presence of a pharmacobezoar consisting of at least 40 tablets in the stomach. Determination of bupropion and its active metabolites (hydroxybupropion, threobupropion, erythrobupropion) was achieved by a liquid chromatographic mass spectrometry (LC-MS/MS) method...
November 2017: Journal of Forensic Sciences
https://read.qxmd.com/read/28507829/bupropion-induced-acute-dystonia-with-dose-escalation-and-use-of-naranjo-nomogram
#15
Nawal Wasif, Komal Wasif, Muhammad W Saif
Acute drug-induced dystonia is commonly associated with antipsychotic drugs, antidepressants, antiemetics, and other medications. Bupropion (Wellbutrin and Zyban) is one of the most frequently prescribed antidepressants in the United States and Canada and smoking cessation aid. However, only few reported cases have been published of acute dystonia including dystonia after discontinuation of bupropion and even after a single dose of bupropion. Here, we report another case concerning an acute dystonia resulting from bupropion after dose escalation...
April 12, 2017: Curēus
https://read.qxmd.com/read/27813651/a-systematic-review-of-the-use-of-bupropion-for-attention-deficit-hyperactivity-disorder-in-children-and-adolescents
#16
REVIEW
Qin Xiang Ng
INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neuropsychiatric disorders of childhood and adolescence. Stimulants are usually the first choice of drug; however, as many as 20% of patients do not respond to them. Stimulants may also worsen comorbid sleep, mood, and anxiety disorders, and they are associated with problems of misuse and diversion. Bupropion, a dopamine and norepinephrine reuptake inhibitor, is a promising nonstimulant alternative with reports of positive outcomes for ADHD management in both adolescent and adult populations...
March 2017: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/27379819/utilizing-a-two-stage-design-to-investigate-the-safety-and-potential-efficacy-of-monthly-naltrexone-plus-once-daily-bupropion-as-a-treatment-for-methamphetamine-use-disorder
#17
JOURNAL ARTICLE
Larissa J Mooney, Maureen P Hillhouse, Christie Thomas, Alfonso Ang, Gaurav Sharma, Garth Terry, Linda Chang, Robrina Walker, Madhukar Trivedi, David Croteau, Steven Sparenborg, Walter Ling
OBJECTIVES: This 2-stage open-label pilot study evaluated the safety and potential efficacy of naltrexone + bupropion as a pharmacotherapy for methamphetamine (MA) use disorder. METHODS: The study was conducted in 2 stages of recruitment across 3 sites; 20 participants were enrolled in stage 1 and 29 participants were enrolled in stage 2. Eight weeks of open-label pharmacotherapy with a combination of extended-release injectable naltrexone (XR-NTX; Vivitrol) plus extended-release oral bupropion (BRP; Wellbutrin XL) were provided with a smartphone-assisted medication adherence platform...
2016: Journal of Addiction Medicine
https://read.qxmd.com/read/27053517/drugs-to-treat-obesity-do-they-work
#18
REVIEW
Sarah Kim
Obesity is a disease that has historically eluded effective medical therapy. Prior to 2012, phentermine and orlistat were the only medications available to treat obesity in the USA, with phentermine approved only for short-term use. However, as of 2015, the repertoire of pharmacological agents available to treat obesity has greatly expanded to include four new drugs: lorcaserin, phentermine/topiramate extended release (ER), naltrexone ER/wellbutrin ER and liraglutide. Each has a unique mechanism of action and all are intended for long-term use...
July 2016: Postgraduate Medical Journal
https://read.qxmd.com/read/25087976/the-development-and-validation-of-a-turbulent-flow-liquid-chromatography-tandem-mass-spectrometric-method-for-the-simultaneous-quantification-of-citalopram-sertraline-bupropion-and-hydroxybupropion-in-serum
#19
JOURNAL ARTICLE
Athena K Petrides, Joshua Moskowitz, Kamisha L Johnson-Davis, Paul J Jannetto, Loralie J Langman, William Clarke, Mark A Marzinke
OBJECTIVES: Depression is a rapidly growing issue in the United States. There are many drug classes that may be used to treat depression, including the selective serotonin-reuptake inhibitors (SSRIs) citalopram (Celexa®) and sertraline (Zoloft®), as well as the aminoketone bupropion (Wellbutrin®). However, therapeutic efficacy and treatment success is often variable, requiring changes in dosing regimens or drug selection. Methods for drug quantification can become important tools in the assessment of drug efficacy to optimize treatment regimens...
October 2014: Clinical Biochemistry
https://read.qxmd.com/read/24533470/female-clitoral-priapism-an-over-the-counter-option-for-management
#20
JOURNAL ARTICLE
Cecile A Unger, Mark D Walters
INTRODUCTION: Female priapism is a rare condition that is not commonly described in the literature. There are many treatment strategies for the management of priapism, including conservative and safe over-the-counter options. AIM: To describe a case of a woman who presented with clitoral priapism, who was managed conservatively with a simple over-the-counter treatment plan. METHODS: A 29-year-old gravida 0 para 0 presented to the emergency room with painful clitoral priapism lasting for 5 days...
September 2014: Journal of Sexual Medicine
keyword
keyword
11912
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.